VIROLOGICAL ANALYSIS OF PATIENTS RECEIVING TELAPREVIR ADMINISTERED Q8H OR Q12H WITH PEGINTERFERON-ALFA-2A OR -ALFA-2B AND RIBAVIRIN IN TREATMENT-NAiVE PATIENTS WITH GENOTYPE 1 HEPATITIS C: STUDY C208

被引：0
|
作者：
Marcellin, Patrick [1 ]
Forns, Xavier [2 ]
Goeser, Tobias [3 ]
Ferenci, Peter [4 ]
Nevens, Frederik [5 ]
Carosi, Giampiero [6 ]
Drenth, Joost P. [7 ]
De Backer, Koen [8 ]
van Heeswijk, Rudolf [8 ]
Luo, Donghan [9 ]
Picchio, Gaston [9 ]
Beumont-Mauviel, Maria [8 ]
机构：
[1] Hop Beaujon, Liver Unit, Clichy, France
[2] Univ Barcelona, Barcelona, Spain
[3] Klinikum Univ Koln, Cologne, Germany
[4] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria
[5] Univ Hosp Gasthuisberg, Dept Hepatol, B-3000 Leuven, Belgium
[6] Univ Brescia, Clin Infect & Trop Dis, Brescia, Italy
[7] Radboud Univ Nijmegen, Ctr Med, NL-6525 ED Nijmegen, Netherlands
[8] Tibotec BVBA, Mechelen, Belgium
[9] Tibotec Inc, Yardley, PA USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
194
引用
收藏
页码：395A / 395A
页数：1
相关论文
共 50 条
  • [1] On-Treatment Response-Guided Therapy With Telaprevir Q8h or Q12h Combined With Peginterferon Alfa-2a or Peginterferon Alfa-2B and Ribavirin in Treatment-NaiVE Genotype 1 Hepatitis C (Study C208)
    Marcellin, Patrick
    Forns, Xavier
    Goeser, Tobias
    Ferenci, Peter
    Nevens, Frederik
    Carosi, Giampiero
    Drenth, Joost P. H.
    Serfaty, Lawrence
    De Backer, Koen
    van Heeswijk, Rolf
    Luo, Don
    De Meyer, Sandra
    Beumont-Mauviel, Maria
    GASTROENTEROLOGY, 2010, 138 (05) : S847 - S847
  • [2] ON-TREATMENT RESPONSE-GUIDED THERAPY WITH TELAPREVIR Q8H OR Q12H COMBINED WITH PEGINTERFERON ALFA-2A PEGINTERFERON ALFA-2B AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HEPATITIS C (STUDY C208)
    Forns, X.
    Marcellin, P.
    Ferenci, P.
    Goeser, T.
    Nevens, F.
    Carosi, G.
    Drenth, J. P.
    Serfaty, L.
    De Backer, K.
    van Heeswijk, R.
    Luo, D.
    Picchio, G.
    Beaumont, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S26 - S26
  • [3] PHASE 2 STUDY OF TELAPREVIR ADMINISTERED Q8H OR Q12H WITH PEGINTERFERON-ALFA-2A OR-ALFA-2B AND RIBAVIRIN IN TREATMENT-NAiVE SUBJECTS WITH GENOTYPE 1 HEPATITIS C: WEEK 4 INTERIM RESULTS
    Forns, Xavier
    Marcellin, Patrick
    Goeser, Tobias
    Ferenci, Peter
    Nevens, Frederik
    Carosi, Giampiero
    Drenth, Joost P.
    De Backer, Koen
    van Heeswijk, Rudolf
    Vangeneugden, Tony J.
    Picchio, Gaston
    Beumont-Mauviel, Maria
    HEPATOLOGY, 2008, 48 (04) : 1136A - 1137A
  • [4] PHASE 2 STUDY OF TELAPREVIR ADMINISTERED Q8H OR Q12H WITH PEGINTERFERON-ALFA-2A OR -ALFA-2B AND RIBAVIRIN IN TREATMENT-NAiVE SUBJECTS WITH GENOTYPE 1. HEPATITIS C: WEEK 4 INTERIM RESULTS (vol 48, pg 4, 2008)
    Forns, X.
    Marcellin, P.
    Goeser, T.
    Ferenci, P.
    Nevens, F.
    Carosi, G.
    Drenth, J. P.
    De Backer, K.
    van Heeswijk, R.
    Vangeneugden, T. J.
    Picchio, G.
    Beumont-Mauviel, M.
    HEPATOLOGY, 2008, 48 (06) : 2093 - 2093
  • [5] TELAPREVIR (TVR) q8h OR q12h COMBINED WITH EITHER PEGINTERFERON (PEG-IFN, P) ALFA-2A OR ALFA-2B AND RIBAVIRIN (RBV, R) IN TREATMENT-NAIVE GENOTYPE 1 HEPATITIS C: FINAL RESULTS OF THE RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE 2 STUDY C208
    Colombo, M.
    Rumi, M. G.
    Carosi, G.
    Puoti, M.
    Marcellin, P.
    Forns, X.
    Goeser, T.
    Ferenci, P.
    Nevens, F.
    Drenth, J. P.
    Serfaty, L.
    Beumont-Mauviel, M.
    Picchio, G.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S6 - S7
  • [6] ACTIVITY OF TELAPREVIR MONOTHERAPY OR IN COMBINATION WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE 4 HEPATITIS-C PATIENTS: FINAL RESULTS OF STUDY C210
    Benhamou, Yves
    Moussalli, Joseph
    Ratziu, Vlad
    Lebray, Pascal
    de Backer, Katrien
    Ghys, Anne
    van Heeswijk, Rolf
    Luo, Donghan
    Picchio, Gaston
    Beumont, Maria
    HEPATOLOGY, 2010, 52 (04) : 719A - 720A
  • [7] A pilot study of add-on oral hypoglycemic agents in treatment-naive genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin
    Hsu, Ching-Sheng
    Hsu, Shih-Jer
    Lin, Hans Hsienhong
    Tseng, Tai-Chung
    Wang, Chia-Chi
    Chen, Ding-Shinn
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (10) : 716 - 721
  • [8] Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C:: a randomized controlled trial
    Bruno, S
    Cammà, C
    Di Marco, V
    Rumi, M
    Vinci, M
    Camozzi, M
    Rebucci, C
    Di Bona, D
    Colombo, M
    Craxì, A
    Mondelli, MU
    Pinzello, G
    JOURNAL OF HEPATOLOGY, 2004, 41 (03) : 474 - 481
  • [9] Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study
    Norio Hayashi
    Makoto Nakamuta
    Tetsuo Takehara
    Hiromitsu Kumada
    Akiko Takase
    Anita Yee Mei Howe
    Steven W. Ludmerer
    Niloufar Mobashery
    Journal of Gastroenterology, 2016, 51 : 390 - 403
  • [10] Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study
    Hayashi, Norio
    Nakamuta, Makoto
    Takehara, Tetsuo
    Kumada, Hiromitsu
    Takase, Akiko
    Howe, Anita Yee Mei
    Ludmerer, Steven W.
    Mobashery, Niloufar
    JOURNAL OF GASTROENTEROLOGY, 2016, 51 (04) : 390 - 403
12345